Skip to main content

bioMérieux to Create 44 Jobs in Durham County

By Jeremy Summers, NCBiotech Writer

Medical instruments manufacturer bioMérieux Inc. will create 44 new jobs as the company expands its Durham facility.

Partners in the project include the North Carolina Biotechnology Center, the N.C. Department of Commerce, the N.C. Community College System, Durham County and the Greater Durham Chamber of Commerce.

The announcement came earlier this week from Governor Pat McCrory and Commerce Secretary Sharon Decker.

“Companies are choosing to invest in our state because of our state’s strong workforce,” said Governor McCrory. “This announcement strengthens North Carolina’s position as a leader in bioscience and advanced manufacturing.”

The company will create 44 jobs and invest $48.3 million in Durham over the next three years. Expansion will be made possible through a performance-based grant of up to $220,000 from the One North Carolina Fund, a state grant program that promotes technology-based industries. The grant is contingent upon proof of job creation and receipt of a local funding match.

“bioMérieux has a long and treasured history with North Carolina, its skilled and educated workforce has enabled us to become a leading innovator and supplier of diagnostic equipment,” said Marc Mackowiak, president and chief executive officer of bioMérieux Inc.  “I applaud the One North Carolina Fund, it is a forward thinking initiative that will drive infrastructure and economic development in our state.” 

Recognized as a world leader in the field of in vitro diagnostics for half a century, bioMérieux has a presence in more than 160 countries through 41 subsidiary companies and an expansive network of distributors. In 2012, the company reached $2 billion in revenues.

The company provides diagnostic solutions, including reagents, instruments and software, which pinpoint the source of disease and contamination in order to improve patient health and ensure consumer safety. These products provide high medical value results for cancer screening and monitoring and cardiovascular emergencies. The company also uses its equipment to detect microorganisms in agri-food, pharmaceutical and cosmetic products.

Currently, 630 are employed at bioMérieux’s Durham facility. Salaries for the new jobs will vary by job function, but the average annual payroll for these new jobs will be $2.2 million.

“The N.C. Department of Commerce is committed to working with companies to spur job creation,” said Secretary Decker. “We congratulate bioMérieux for investing in North Carolina once again.”

About the One North Carolina Fund

The One North Carolina Fund is a grant program launched in 2005 by the North Carolina Department of Commerce’s Office of Science and Technology.

The program provides financial assistance, through local governments, to attract business projects that will stimulate economic activity and create new jobs throughout the state. Participating companies receive no money up front and must meet standards in job creation and investment performance in order to qualify for grant funds. 

According to Commerce, the program is responsible for creating or retaining more than 500 high-wage private-sector jobs and helping more than 200 small businesses commercialize products in technology-based industries, such as biotech.

Add new comment

Refresh Type the characters you see in this picture.
Type the characters you see in the picture; if you can't read them, submit the form and a new image will be generated. Not case sensitive.  Switch to audio verification.